Purkiss Capital Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.5M Buy
13,798
+323
+2% +$75.3K 1.33% 14
2026
Q1
$3.29M Sell
13,475
-43
-0.3% -$10K 1.45% 12
2025
Q4
$2.8M Sell
13,518
-193
-1% -$38.2K 1.31% 15
2025
Q3
$2.54M Sell
13,711
-578
-4% -$99K 1.22% 17
2025
Q2
$2.18M Buy
14,289
+610
+4% +$93.8K 1.21% 15
2025
Q1
$2.27M Buy
13,679
+964
+8% +$151K 1.71% 9
2024
Q4
$1.84M Buy
+12,715
New +$1.97M 1.59% 12

Other funds holding JNJ

Purkiss Capital Advisors's JNJ Position: Q2 2026 in Review

Purkiss Capital Advisors increased its Johnson & Johnson (JNJ) stake by 2.4% in Q2 2026, buying an estimated $75.3K and bringing the position to 13,798 shares worth $3.5M. The position accounts for 1.33% of the portfolio, ranked #14.

Purkiss Capital Advisors first reported a position in JNJ in Q4 2024 and has held it in 7 quarters since. 2,235 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Purkiss Capital Advisors held 13,798 shares of Johnson & Johnson worth $3.5M as of Q2 2026.
  • Purkiss Capital Advisors bought 323 Johnson & Johnson shares in Q2 2026, an estimated $75.3K.
  • Johnson & Johnson made up 1.33% of Purkiss Capital Advisors's portfolio in Q2 2026, its #14 holding.
  • Purkiss Capital Advisors first reported a position in Johnson & Johnson in Q4 2024 and has held it in 7 quarters since.
  • 2,235 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Purkiss Capital Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.